Tanshinone IIA mediates SMAD7-YAP interaction to inhibit liver cancer growth by inactivating the transforming growth factor beta signaling pathway
Author(s) -
Lifang Ma,
Hongyuan Jiang,
Xin Xu,
Congcong Zhang,
Yongjie Niu,
Zhixian Wang,
Yuquan Tao,
Yan Li,
Feng Cai,
Xiao Zhang,
Xinghe Wang,
Yongchun Yu
Publication year - 2019
Publication title -
aging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.473
H-Index - 90
ISSN - 1945-4589
DOI - 10.18632/aging.102420
Subject(s) - salvia miltiorrhiza , transforming growth factor beta , cell growth , cancer research , transforming growth factor , apoptosis , liver cancer , cancer , signal transduction , cancer cell , chemistry , microbiology and biotechnology , pharmacology , biology , medicine , traditional chinese medicine , biochemistry , hepatocellular carcinoma , pathology , alternative medicine
Tanshinone IIA (TanIIA)-an active constituent of Salvia miltiorrhiza , a traditional Chinese medicinal plant-is known to have blood circulation promotion and anti-tumor properties. Tan IIA can induce tumor cell death and inhibit tumor growth. However, the functions and underling molecular mechanisms of Tan IIA action on human liver cancer cells remain poorly understand. In this study, we found that Tanshinone IIA mediates SMAD7-YAP interaction to induce liver cancer cell apoptosis and inhibit cell growth and migration by inactivating the transforming growth factor beta (TGF-β) signaling pathway. Our findings showed that the Tan IIA-SMAD7-YAP regulatory network might be an effective strategy for liver cancer treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom